Gene Test for Chemo Video

Chemotherapy can cause devastating side effects. What if cancer patients could skip the chemo and still win the battle against their disease?
Read the full transcript »

Jennifer Matthews: Eleanor Garrity has a newfound appreciation for life's simple pleasures like combing her hair. Eleanor Garrity: I can't imagine the shock of going into the shower and you hair is just falling out in clumps and clumps. Jennifer Matthews: Losing her hair because of chemotherapy was a real threat just a few months ago. Diagnosed with breast cancer, Eleanor had a mastectomy. Chemo was then scheduled to ensure the cancer would not return. Eleanor Garrity: I was afraid that if I started to take chemo, it would make me sick. Jennifer Matthews: She was spared thanks to a new genetic test that identifies which genes are turned on or off in a breast tumor. Dr. Joseph Sparano: The oncotype test is a multi-gene that's test performed on breast tumor tissue that can more accurately predict outcome prognosis. Jennifer Matthews: The results are a score from zero to 100. At 17 or below, there's a low risk for breast cancer recurrence, so doctors recommend hormone therapy only. A score of 31 or above means chemo should be added. For those in between, the proper therapy is not so clear, which is why Dr. Sparano is leading a nationwide clinical trial. Dr. Joseph Sparano: If chemo is necessary in this group is there a threshold effect or is there a specific recurrence score at which we begin seeing a benefit from chemotherapy. You can see that you fall into the low-risk group. Jennifer Matthews: That news changed Eleanor's life and has her walking on the road to good health. This is Jennifer Matthews reporting.

Advertisement
Advertisement
Advertisement